$CTSH

US halts Cognizant's green-card filings amid Trump's visa fraud crackdown

The US has suspended Cognizant's permanent labor certification filings amid a visa fraud probe. The move is part of a broader crackdown by the Trump administration. Cognizant, a major H-1B sponsor, faces scrutiny over alleged fraud in its visa programs. The suspension bars new PERM applications until the investigation concludes. According to US Citizenship and Immigration Services, Cognizant had 3,510 H-1B visa approvals as of June 30, down from 9,413 in 2020.

Original reporting
Published Sep 8, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 11:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
US halts Cognizant's green-card filings amid Trump's visa fraud crackdown — source image
Decision brief

The 30-second read

$CTSHBearishMed
01

Why it matters

Regulatory enforcement could increase compliance costs and delay talent acquisition for affected firms.

02

Market read

First‑report enforcement action on major H‑1B sponsors, likely to trigger short‑term price declines and sector‑wide risk reassessment.

03

What to watch

Potential for Cognizant to shift hiring to alternative visa categories or increase domestic hiring, mitigating long‑term impact.

Relevance 8/10Novelty 8/10Timing: immediate (reported on Sep 8, 2026)

Background

The Trump administration's fraud task force has intensified scrutiny of H‑1B and PERM programs, targeting large sponsors.

Company-level read

Ticker impact

$CTSHBearishHigh confidence
Context

US Department of Labor suspended Cognizant's permanent labour certification (PERM) filings, halting new H-1B and green‑card sponsorships.

Expected impact

Short‑term downside pressure; potential 3‑5% decline as investors reassess hiring costs.

Evidence & confidence

Enforcement action is a primary disclosure affecting a large cap; market typically reacts negatively to visa‑related restrictions.

Market effects

Raises scrutiny on the broader US IT services sector and other H‑1B dependent firms.

Potential short‑term weakness in US tech stocks with high foreign‑worker reliance.

May prompt similar investigations in other jurisdictions, affecting global IT staffing dynamics.

Counterpoint

If the investigation leads to limited penalties, the market may view the suspension as temporary, offering a buying opportunity on dip.

Key entities

  • Cognizant

    US‑listed IT services firm (CTSH) subject to PERM filing suspension.

  • Cloudera

    US‑listed data‑management firm (CLDR) also affected by PERM suspension.

  • U.S. Department of Labor

    Agency enforcing the suspension of PERM filings.

Related articles

$CTSHMedAI 8/10

Cognizant Stock Falls 3.8%—Is CTSH Cheap at 10 Times Earnings?

Cognizant (CTSH) shares fell 3.8% to $59.92, trading at 10.4x its 2026 EPS forecast. Q2 revenue rose 4.5% to $5.48B, with adjusted EPS up 4.6% to $1.37. Bookings declined 6% YoY, raising concerns. Management revised revenue growth guidance to 4.0%-5.5% and raised EPS guidance to $5.70-$5.82. Investors weigh AI's impact on growth and margins.

$CTSHHighAI 8/10

US Suspends Cognizant’s PERM Filings, Who's Next?

The US Department of Labor suspended Cognizant's PERM filings, citing potential fraud in H-1B and PERM programs. The investigation involves the White House Fraud Task Force. Cognizant's new filings are blocked, but existing approvals and H-1B visas remain unaffected. This action may increase scrutiny on other IT firms like TCS, Infosys, and Wipro.

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.